Medicina
Departamento
Magna Graecia University
Catanzaro, ItaliaPublicaciones en colaboración con investigadores/as de Magna Graecia University (10)
2020
-
Characteristics and treatment regimens across ERS SHARP severe asthma registries
European Respiratory Journal, Vol. 55, Núm. 1
2019
-
Clinical Events After Deferral of LAD Revascularization Following Physiological Coronary Assessment
Journal of the American College of Cardiology, Vol. 73, Núm. 4, pp. 444-453
-
Comparison of Major Adverse Cardiac Events between Instantaneous Wave-Free Ratio and Fractional Flow Reserve-Guided Strategy in Patients with or Without Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial
JAMA Cardiology, Vol. 4, Núm. 9, pp. 857-864
-
Sex Differences in Instantaneous Wave-Free Ratio or Fractional Flow Reserve–Guided Revascularization Strategy
JACC: Cardiovascular Interventions, Vol. 12, Núm. 20, pp. 2035-2046
2018
-
Pre-Angioplasty Instantaneous Wave-Free Ratio Pullback Predicts Hemodynamic Outcome In Humans With Coronary Artery Disease: Primary Results of the International Multicenter iFR GRADIENT Registry
JACC: Cardiovascular Interventions, Vol. 11, Núm. 8, pp. 757-767
-
Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes
JACC: Cardiovascular Interventions, Vol. 11, Núm. 15, pp. 1437-1449
2017
-
Use of the instantaneous wave-free ratio or fractional flow reserve in PCI
New England Journal of Medicine, Vol. 376, Núm. 19, pp. 1824-1834
2016
-
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Oncology, Vol. 17, Núm. 3, pp. 367-377
2014
-
Real-time use of instantaneous wave-free ratio: Results of the ADVISE in-practice: An international, multicenter evaluation of instantaneous wave-free ratio in clinical practice
American Heart Journal, Vol. 168, Núm. 5, pp. 739-748
2013
-
Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study
The Lancet, Vol. 381, Núm. 9868, pp. 735-743